Mark Sheptoff Financial Planning, LLC Pasithea Therapeutics Corp. Transaction History

Mark Sheptoff Financial Planning, LLC

  • $176 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
BUY
$0.44 - $0.63 $1,462 - $2,093
3,323 New
3,323 $1,000
Q2 2022

Aug 11, 2022
SELL
$16.52 - $27.0 $792,960 - $1.3 Million
-48,000 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$19.4 - $35.8 $931,199 - $1.72 Million
48,000 New
48,000 $62,000

About Pasithea Therapeutics Corp.

KTTA Quotes by TradingView
  • Ticker KTTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,398,700
  • Market Cap $157M
  • Description
  • Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 ...
More about KTTA
Track This Portfolio

Track Mark Sheptoff Financial Planning, LLC Portfolio

Follow Mark Sheptoff Financial Planning, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mark Sheptoff Financial Planning, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mark Sheptoff Financial Planning, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email